| Brain charts for the human lifespan RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ... Nature 604 (7906), 525-533, 2022 | 797 | 2022 |
| Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation S Villeneuve, GD Rabinovici, BI Cohn-Sheehy, C Madison, N Ayakta, ... Brain 138 (7), 2020-2033, 2015 | 381 | 2015 |
| Associations between serum cholesterol levels and cerebral amyloidosis B Reed, S Villeneuve, W Mack, C DeCarli, HC Chui, W Jagust JAMA neurology 71 (2), 195-200, 2014 | 280 | 2014 |
| Mild cognitive impairment in moderate to severe COPD: a preliminary study S Villeneuve, V Pepin, S Rahayel, JA Bertrand, M de Lorimier, A Rizk, ... Chest 142 (6), 1516-1523, 2012 | 214 | 2012 |
| Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people M Wirth, S Villeneuve, CM Haase, CM Madison, H Oh, SM Landau, ... JAMA neurology 70 (12), 1512-1519, 2013 | 190 | 2013 |
| Gene–environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden M Wirth, S Villeneuve, R La Joie, SM Marks, WJ Jagust Journal of Neuroscience 34 (25), 8612-8617, 2014 | 147 | 2014 |
| Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps N Bhattacharyya, S Villeneuve, VN Joish, C Amand, L Mannent, N Amin, ... The Laryngoscope 129 (9), 1969-1975, 2019 | 146 | 2019 |
| Odor identification as a biomarker of preclinical AD in older adults at risk ME Lafaille-Magnan, J Poirier, P Etienne, J Tremblay-Mercier, J Frenette, ... Neurology 89 (4), 327-335, 2017 | 136 | 2017 |
| Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults M Wirth, CM Haase, S Villeneuve, J Vogel, WJ Jagust Neurobiology of aging 35 (8), 1873-1882, 2014 | 134 | 2014 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 130 | 2022 |
| INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease PF Meyer, J Tremblay-Mercier, J Leoutsakos, C Madjar, ... Neurology 92 (18), e2070-e2080, 2019 | 130 | 2019 |
| Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions S Villeneuve, BR Reed, CM Madison, M Wirth, NL Marchant, S Kriger, ... Neurology 83 (1), 40-47, 2014 | 111 | 2014 |
| Association of gray matter atrophy with age, β-amyloid, and cognition in aging H Oh, C Madison, S Villeneuve, C Markley, WJ Jagust Cerebral cortex 24 (6), 1609-1618, 2014 | 102 | 2014 |
| Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors F Peters, S Villeneuve, S Belleville Journal of Alzheimer's disease 38 (2), 307-318, 2014 | 102 | 2014 |
| Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI LL Chao, C DeCarli, S Kriger, D Truran, Y Zhang, J Laxamana, ... PloS one 8 (6), e65175, 2013 | 96 | 2013 |
| Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated tau and AV1451 positron emission tomography PF Meyer, AP Binette, J Gonneaud, JCS Breitner, S Villeneuve, ... JAMA neurology 77 (4), 508-516, 2020 | 93 | 2020 |
| Repetitive negative thinking is associated with amyloid, tau, and cognitive decline NL Marchant, LR Lovland, R Jones, A Pichet Binette, J Gonneaud, ... Alzheimer's & Dementia 16 (7), 1054-1064, 2020 | 86 | 2020 |
| Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease J Tremblay-Mercier, C Madjar, S Das, AP Binette, SOM Dyke, P Étienne, ... NeuroImage: Clinical 31, 102733, 2021 | 78 | 2021 |
| The potential applications of Apolipoprotein E in personalized medicine S Villeneuve, D Brisson, NL Marchant, D Gaudet Frontiers in aging neuroscience 6, 154, 2014 | 72 | 2014 |
| Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment S Villeneuve, S Belleville, F Massoud, C Bocti, S Gauthier Dementia and geriatric cognitive disorders 27 (4), 375-381, 2009 | 71 | 2009 |
Judes PoirierMcGill University, Douglas Mental Health Institute在 mcgill.ca 的电子邮件经过验证
